Pricing Log in Create free account

Annovis Bio, Inc. (ANVS) vs Sangamo Therapeutics, Inc. (SGMOQ)

Annovis Bio, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Annovis Bio, Inc. and Sangamo Therapeutics, Inc. are of similar size ($44.8M and $41.9M). Annovis Bio, Inc. has the higher net margin (0.00% vs −356.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Annovis Bio, Inc. leads on 7 and Sangamo Therapeutics, Inc. on 3.

Valuation

Metric ANVS SGMOQ Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.24 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1.24 9.21
Earnings yield (180.81%) (345.45%) (33.15%)
Free cash flow yield (116.68%) (211.06%) (25.50%)

Profitability

Metric ANVS SGMOQ Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (357.55%) 0.00%
Net margin 0.00% (356.89%) 0.00%
Free cash flow margin 0.00% (261.76%) 0.00%
Return on equity (703.68%) 1,755.72% (56.36%)
Return on assets (227.74%) (168.79%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANVS SGMOQ Biotechnology median
Revenue growth (TTM) — (45.80%) 6.02%
EPS growth (last fiscal year) 39.39% 10.20% 30.26%
Revenue growth, 5-year CAGR — (19.66%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANVS SGMOQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.47 0.70 4.72
Net debt to EBITDA 0.66 0.18 0.96

Dividend

Metric ANVS SGMOQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANVS SGMOQ Biotechnology median
Market cap 44.81m 41.89m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack